These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 25249380)
1. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life. Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380 [TBL] [Abstract][Full Text] [Related]
2. Opioids for Relief of Dyspnea Immediately Before Death in Patients With Noncancer Disease: A Case Series Study. Murakami M Am J Hosp Palliat Care; 2019 Aug; 36(8):734-739. PubMed ID: 30803242 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study. Clemens KE; Klaschik E Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302 [TBL] [Abstract][Full Text] [Related]
4. Opioid use in palliative care of children and young people with cancer. Hewitt M; Goldman A; Collins GS; Childs M; Hain R J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896 [TBL] [Abstract][Full Text] [Related]
5. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit. Botterman J; Criel N Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611 [TBL] [Abstract][Full Text] [Related]
6. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan? Hu WY; Chiu TY; Cheng SY; Chen CY J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653 [TBL] [Abstract][Full Text] [Related]
7. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey. Salvato C; Aretini G; Serraglia D; Terrazzani G; Debetto P; Giusti P; Chinellato A Pharmacol Res; 2003 Jul; 48(1):75-82. PubMed ID: 12770518 [TBL] [Abstract][Full Text] [Related]
8. A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids. Uekuzu Y; Higashiguchi T; Futamura A; Ito A; Mori N; Murai M; Ohara H; Awa H; Chihara T Biol Pharm Bull; 2017 Mar; 40(3):278-283. PubMed ID: 27980244 [TBL] [Abstract][Full Text] [Related]
9. Methadone titration in opioid-resistant cancer pain. Scholes CF; Gonty N; Trotman IF Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950 [TBL] [Abstract][Full Text] [Related]
10. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review. Maeda T; Hayakawa T J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633 [TBL] [Abstract][Full Text] [Related]
11. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. Dougherty M; DeBaun MR J Pediatr; 2003 Apr; 142(4):373-6. PubMed ID: 12712053 [TBL] [Abstract][Full Text] [Related]
12. Intravenous morphine consumption in outpatients with cancer during their last week of life--an analysis based on patient-controlled analgesia data. Schiessl C; Sittl R; Griessinger N; Lutter N; Schuettler J Support Care Cancer; 2008 Aug; 16(8):917-23. PubMed ID: 17960428 [TBL] [Abstract][Full Text] [Related]
13. Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians' attitudes. Bendiane MK; Peretti-Watel P; Pegliasco H; Favre R; Galinier A; Lapiana JM; Obadia Y J Opioid Manag; 2005; 1(1):25-30. PubMed ID: 17315408 [TBL] [Abstract][Full Text] [Related]
14. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Boyd KJ; Kelly M Palliat Med; 1997 Jul; 11(4):277-81. PubMed ID: 9373578 [TBL] [Abstract][Full Text] [Related]
15. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain. Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811 [TBL] [Abstract][Full Text] [Related]
16. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain. Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396 [TBL] [Abstract][Full Text] [Related]
17. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694 [TBL] [Abstract][Full Text] [Related]
18. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Mercadante S; Villari P; Ferrera P; Casuccio A Support Care Cancer; 2004 Nov; 12(11):762-6. PubMed ID: 15206014 [TBL] [Abstract][Full Text] [Related]
19. High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy. Bercovitch M; Waller A; Adunsky A Cancer; 1999 Sep; 86(5):871-7. PubMed ID: 10463988 [TBL] [Abstract][Full Text] [Related]
20. The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients. Reddy A; Vidal M; Stephen S; Baumgartner K; Dost S; Nguyen A; Heung Y; Kwan S; Wong A; Pangemanan I; Azhar A; Tayjasanant S; Rodriguez E; Waletich J; Lim KH; Wu J; Liu D; Williams J; Yennurajalingam S; Bruera E J Pain Symptom Manage; 2017 Sep; 54(3):280-288. PubMed ID: 28711751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]